Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

180.45EUR
11:35am EDT
Change (% chg)

€2.65 (+1.49%)
Prev Close
€177.80
Open
€178.00
Day's High
€180.45
Day's Low
€177.55
Volume
30,044
Avg. Vol
27,922
52-wk High
€180.45
52-wk Low
€109.00

Select another date:

Thu, Apr 20 2017

BRIEF-Biomerieux Q1 Consolidated sales rise to 568 million euros

* Consolidated sales rose to 568 million euros ($609.18 million) for the first three months of 2017, up from 489 million euros in the same period one year earlier Source text: http://bit.ly/2piknxJ Further company coverage: ($1 = 0.9324 euros) (Gdynia Newsroom:)

BRIEF-Biomerieux receives FDA 510(k) clearance for BacT/ALERT VIRTUO fully automated blood culture system

* Biomerieux receives FDA 510(k) clearance for its BacT/ALERT VIRTUO fully automated blood culture system Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Turkey's BIM 2016 net profit rises 15 percent

ISTANBUL, March 7 Turkish retailer BIM posted a net profit of 670.9 million lira ($181 million) in 2016, up 15 percent from a earlier, it said in a statement to the Istanbul stock exchange late on Monday.

BRIEF-Biomerieux FY sales up 7.1 pct as reported at 2.10 billion euros

* Board of directors will recommend that shareholders at annual meeting on May 30 approve a dividend of 1.00 euros per share

BRIEF-Biomerieux launches first FDA-cleared procalcitonin assay

* Biomérieux’s VIDAS BRAHMS PCT becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Biomerieux and Banyan Biomarkers partner to develop, validate and market blood-based biomarkers for traumatic brain injury

* Biomerieux and Banyan Biomarkers partner to develop, validate and market blood-based biomarkers for traumatic brain injury

BRIEF-Biomerieux 2016 sales up at 2,103 million euros

* Remarkable growth in sales in 2016, up 9.6 pct like-for-like, lifted by all regions and all strategic lines

BRIEF-Biomerieux launches system for extraction of DNA and RNA

* Launches EMAG, a new generation automated system for extraction of DNA and RNA

Select another date:

More From Around the Web